Reporter Name	Relationship	Type	Amount	SEC Filing
Cappello Joseph	Chief Technical Officer, 10% Owner	Sell	$14,361	Form 4
Yu Yong	SVP, Clinical Development, 10% Owner	Sell	$16,031	Form 4
Zindrick Thomas	President and CEO, 10% Owner	Sell	$66,369	Form 4

Several executives at GENELUX Corp, including the Chief Technical Officer, the SVP of Clinical Development, and the President and CEO, have reported selling shares of the company's common stock to cover estimated taxes related to the vesting of restricted stock units.

Joseph Cappello, the Chief Technical Officer and a 10% owner, sold 3,706 shares across three transactions on August 21 and November 17, 2025, at prices ranging from $3.3267 to $5.3694 per share, totaling $14,361. Following these sales, Cappello directly owns 156,060 shares.

Yu Yong, the SVP of Clinical Development and a 10% owner, sold 4,192 shares in two transactions on August 21 and November 17, 2025, at prices of $3.3574 and $5.3694 per share, respectively, totaling an undisclosed amount. Post-transaction, Yong directly owns 145,844 shares.

Thomas Zindrick, the President and CEO and a 10% owner, sold 17,182 shares in two transactions on August 21 and November 17, 2025, at $3.3267 and $5.3694 per share, respectively, totaling $66,369. Zindrick's direct ownership stands at 538,431 shares following these transactions.

GENELUX Corp Executives Sell Shares to Cover Taxes